Viewing Study NCT00641056


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-05 @ 11:07 PM
Study NCT ID: NCT00641056
Status: COMPLETED
Last Update Posted: 2015-06-15
First Post: 2008-03-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
Sponsor: AstraZeneca
Organization: